Adjuvant Treatment of Tongue and Floor of the Mouth Cancers
- 1 January 1979
- book chapter
- Published by Springer Nature
- Vol. 68, 309-317
- https://doi.org/10.1007/978-3-642-81332-0_47
Abstract
Chemotherapy of head and neck cancers gives objective responses in about 30% of the cases, sometimes spectacular but never durable enough to significantly after prognosis. One of its limitations seems to be related to the tumor mass. It is, therefore, important to test chemotherapy on the residual cells, which are not visible, but are responsible for local, regional, or distant relapses after apparently satisfactory local treatment. These residual cells are also the proposed target for adjuvant immunotherapy.Keywords
This publication has 0 references indexed in Scilit: